• HOME
  • RESEARCH
  • PEOPLE
    • Matthew S. Davids
    • Current Lab Members >
      • Christine Ryan, MD
      • Stephen Chong, PhD
      • Fen Zhu, PhD
      • Johannes Hildebrand, MSc
      • Mary Collins, BS
      • Liam Hackett, AB
    • Alumni >
      • Charles Herbaux, MD
      • Rebecca Valentin, MD
      • Timothy Lehmberg, B.A.
      • Stephanie Grabow, PhD
      • Simon Husby, MD
  • PUBLICATIONS
  • JOBS
  • SUPPORT US
  • NEWS
    • Awards and Recognition
  • CONTACT
Davids Lab - Translational CLL Research

The Davids Lab
TRANSLATIONAL CLL RESEARCH


2020


Picture

​
2020 ASH Abstract Achievement Award
​Researcher: Stephen Chong, PhD
Title: Re-Wiring BCL-2 Family Anti-Apoptotic Protein Dependencies through Modulating Phosphorylation to Re-Sensitize Venetoclax-Resistant Lymphoid Malignancies to BCL-2 Inhibition

2019


Picture


2019 ASH Abstract Achievement Award
Researcher: Charles Herbaux, MD
Title: 
Characterizing the Anti-Apoptotic Dependencies of T-Cell Prolymphocytic Leukemia Identifies HDAC and JAK/STAT Pathway Inhibitors As Promising Combination Partners to Augment Bcl-2 Targeted Killing By Venetoclax

2018


Picture



​2018 James O. Armitage Clinical Investigator Award
Researcher: Matthew S. Davids, MD, MMSc
For more information on this award, click here.


Picture

2018 ASH Abstract Achievement Award
Researcher: Rebecca Valentin, MD
Title: The Fully Human Anti-CD47 Antibody SRF231 Has Dual-Mechanism Antitumor Activity Against Chronic Lymphocytic Leukemia (CLL) Cells and Increases the Activity of Rituximab and Venetoclax

 HOME | RESEARCH | PEOPLE | PUBLICATIONS | JOBS | SUPPORT US | NEWS | CONTACT 

©2016 Translational CLL Research at Dana-Farber Cancer Institute